Science Explorer Interactive view Map
Company · Vienna · Austria

Pfizer (Austria)

Research works
23
▲ 124% vs 2013–17
Citations
310
13.7 per fractional work
Top-10% rate
31.6%
record average 16.5%
Open access
66%
world 28%

Not ranked overall: Pfizer (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.06× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.30× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 28.54× its world share, 4 worksImmunology and Micro…Chemistry: 0.33× its world share, 0 worksChemistryHealth Professions: 0.19× its world share, 0 worksHealth ProfessionsMedicine: 3.27× its world share, 8 worksMedicineEconomics, Econometrics and Finance: 0.34× its world share, 0 worksEconomics, Econometr…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 28.5×. Every wedge is a field page.

Which keywords describe research at Pfizer (Austria)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Public Health, Pathogen Transmission, Lyme Disease, Tick-Borne Diseases, Pathogenesis, Zoonotic Infections and Genetic Diversity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Epidemiology10▲ 11×16 topics
  2. Public Health7▲ 23×6 topics
  3. Pathogen Transmission5▲ 344×2 topics
  4. Lyme Disease4▲ 555×1 topic
  5. Tick-Borne Diseases4▲ 555×1 topic
  6. Pathogenesis3▲ 27×3 topics
  7. Zoonotic Infections3▲ 213×2 topics
  8. Bunyavirus3▲ 255×1 topic
  9. Genetic Diversity3▲ 24×2 topics
  10. Viral Hemorrhagic Fevers3▲ 255×1 topic
  11. Arboviral Diseases2▲ 129×1 topic
  12. Zika Virus2▲ 129×1 topic
  13. Climate Change2▲ 2.7×3 topics
  14. Globalization2▲ 3.8×2 topics
  15. Clinical Trials1▲ 9.4×2 topics
  16. One Health1▲ 230×1 topic
  17. Zoonotic Diseases1▲ 230×1 topic
  18. Artificial Intelligence1▲ 5.6×2 topics
  19. Business Models1▲ 57×1 topic
  20. Corporate Social Responsibility1▲ 37×1 topic
  21. Digital Transformation1▲ 16×1 topic
  22. Regulatory Challenges1▲ 58×1 topic
  23. Stem Cell Regulation1▲ 200×1 topic
  24. Sustainability1▲ 2.5×1 topic

Which research topics does Pfizer (Austria) publish most on?

By volume in 2022–2025: Vector-borne infectious diseases, Viral Infections and Vectors, Mosquito-borne diseases and control and Zoonotic diseases and public health.

  1. 1 Vector-borne infectious diseases Parasitology 3 works
  2. 2 Viral Infections and Vectors Infectious Diseases 2 works
  3. 3 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 1 works
  4. 4 Zoonotic diseases and public health Public Health, Environmental and Occupational Health 1 works
  5. 5 Biomedical Ethics and Regulation Physiology 1 works
  6. 6 Vector-Borne Animal Diseases Ecology, Evolution, Behavior and Systematics 1 works
  7. 7 Dermatology and Skin Diseases Dermatology 0 works
  8. 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  9. 9 Herpesvirus Infections and Treatments Epidemiology 0 works
  10. 10 Psoriasis: Treatment and Pathogenesis Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.9%not open34.1%

World: 28% of research is openly available.

with international co-authors72.9%domestic only27.1%

World: 19% is written across borders.

How has Pfizer (Austria)'s research output changed?

Output in 2018–2022 was 124% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vienna

All research institutions in Vienna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.